Blog & Announcements

*NOTE: Enrollment is closed for this study* Study Objective The use of cannabinoid derivatives in the treatment of a variety of neurological disorders in humans has recently been explored, particularly in the treatment of chronic ...

The primary objective of this study is to determine the maximum tolerated dose, dose-limiting toxicities, safe starting dose, and pharmacodynamic effect of TANOVEA™ (rabacfosadine for injection) in cats with lymphoma, lymphoid leukemia or multiple myeloma/plasma ...

Pulmonic stenosis is a birth defect in the heart. It is caused by an incomplete pulmonary valve on the right side of the heart. It can result in serious, life-threatening changes in the way that the heart pumps ...

*NOTE: This study is closed/manuscript in progress* The aim of this study is to evaluate client perception of quality of life improvement in Labrador Retrievers with laryngeal paralysis (LP) given doxepin for one month compared to dogs given ...

Patent ductus arteriosus (also called PDA) is a birth defect in the heart. It is caused by incomplete changes in the heart’s circulation when a dog or cat is born. This results in serious, life-threatening ...

Purpose To evaluate the relevance of history and presentation in the evaluation of chronic valve disease in small breed dogs. Case Selection All dogs <20kg and older than 8 years with a significant systolic heart ...

*NOTE: This study is not currently enrolling new patients until further notice* The primary aim of the study is to assess the clinical responses of cats with naturally occurring mild to moderate chronic enteropathy when ...

OBJECTIVE: Lymphoma is one of the most common cancers in dogs. Current treatment options include various types of chemotherapy, including TANOVEA®-CA1 (rabacfosadine for injection), the first FDA conditionally approved drug to treat canine lymphoma. It ...